Vanda Pharmaceuticals (VNDA) Misses Q2 EPS by 5c
Tweet
Share
E-mail
Get Alerts VNDA Hot Sheet
Price: $6.21 +2.64%
EPS Growth %: -30.4%
Financial Fact:
Total operating expenses: 39.14M
Today's EPS Names:
CRMT, More
EPS Growth %: -30.4%
Financial Fact:
Total operating expenses: 39.14M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q2 EPS of $0.03, $0.05 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $46.06 million versus the consensus estimate of $62 million.
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Bending Spoons closes IPO, raises ~$954M on Nasdaq
- Lockheed Martin frontrunner for $3.5B Ultra Maritime deal, sources say - FT
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
